Abcellera, for example, designed Lily’s COVID antibody ... business of drug discovery, find promising targets, and then sell them to pharma to carry out the expensive process of development ...

AI tools are being combined into virtual screening platforms that can accelerate multiple steps in the drug discovery process ... with a PredAI that can model antibody-antigen interactions ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process ...

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

The company will use the seed capital to develop clinical programs, A.I. platforms and its drug candidate pipeline. Manas AI will host its systems on Microsoft (MSFT)’s Azure cloud computing ...

Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...

Irreverent jokes fly a mile a minute with little time to land in this graphic novel adaptation centered on a policeman with a dog’s head protecting his city from his cat arch-nemesis. “Dog Man ...

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved, the ...

These venues for discussion and debate are essential for allowing the scientific process to unfold. The National Academies of Sciences, Engineering, and Medicine are the nation's pre-eminent source of ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.